Cargando…
Mpox vaccination in global perspective: priorities and challenges
After the global panic created by COVID-19, the monkeypox (Mpox) virus emerged as a new challenge for the world population. As of 19 January 2023, a total of 84,733 cases across 110 countries/territories including 80 deaths has been reported. The virus has been transmitted to nonendemic countries in...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10205209/ https://www.ncbi.nlm.nih.gov/pubmed/37228971 http://dx.doi.org/10.1097/MS9.0000000000000550 |
_version_ | 1785045986669756416 |
---|---|
author | Rana, Jigyasa Patel, Shailesh Kumar Agrawal, Aditya Channabasappa, Nikhil K. Niranjan, Ankush K. Chandra Das, Bhabesh Pandey, Megha K. Tiwari, Sita Prasad Gaihre, Milan |
author_facet | Rana, Jigyasa Patel, Shailesh Kumar Agrawal, Aditya Channabasappa, Nikhil K. Niranjan, Ankush K. Chandra Das, Bhabesh Pandey, Megha K. Tiwari, Sita Prasad Gaihre, Milan |
author_sort | Rana, Jigyasa |
collection | PubMed |
description | After the global panic created by COVID-19, the monkeypox (Mpox) virus emerged as a new challenge for the world population. As of 19 January 2023, a total of 84,733 cases across 110 countries/territories including 80 deaths has been reported. The virus has been transmitted to nonendemic countries in a short span of 6 months warranting WHO to declare Mpox, a Public Health Emergency of International Concern on 23 July 2022. As the Mpox virus is crossing geographical boundaries without established transmission patterns, there is an urgent need for new scientific strategies from global researchers to contain it before turning into the next pandemic. The control of Mpox outbreaks primarily relies on various public health measures such as proper surveillance, contact tracing, rapid diagnosis, isolation and care of patients, and vaccination. At present, there are three vaccines viz. ACAM2000, MVABN, and LC16 are in consideration and have been approved in several jurisdictions for ongoing Mpox outbreak. Prioritization of individuals along with the production of specific Mpox vaccine is need of the hour to meet out the global demand of Mpox vaccination. |
format | Online Article Text |
id | pubmed-10205209 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-102052092023-05-24 Mpox vaccination in global perspective: priorities and challenges Rana, Jigyasa Patel, Shailesh Kumar Agrawal, Aditya Channabasappa, Nikhil K. Niranjan, Ankush K. Chandra Das, Bhabesh Pandey, Megha K. Tiwari, Sita Prasad Gaihre, Milan Ann Med Surg (Lond) Correspondence, Commentaries, Perspectives After the global panic created by COVID-19, the monkeypox (Mpox) virus emerged as a new challenge for the world population. As of 19 January 2023, a total of 84,733 cases across 110 countries/territories including 80 deaths has been reported. The virus has been transmitted to nonendemic countries in a short span of 6 months warranting WHO to declare Mpox, a Public Health Emergency of International Concern on 23 July 2022. As the Mpox virus is crossing geographical boundaries without established transmission patterns, there is an urgent need for new scientific strategies from global researchers to contain it before turning into the next pandemic. The control of Mpox outbreaks primarily relies on various public health measures such as proper surveillance, contact tracing, rapid diagnosis, isolation and care of patients, and vaccination. At present, there are three vaccines viz. ACAM2000, MVABN, and LC16 are in consideration and have been approved in several jurisdictions for ongoing Mpox outbreak. Prioritization of individuals along with the production of specific Mpox vaccine is need of the hour to meet out the global demand of Mpox vaccination. Lippincott Williams & Wilkins 2023-04-01 /pmc/articles/PMC10205209/ /pubmed/37228971 http://dx.doi.org/10.1097/MS9.0000000000000550 Text en Copyright © 2023 the Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (https://creativecommons.org/licenses/by/4.0/) (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) |
spellingShingle | Correspondence, Commentaries, Perspectives Rana, Jigyasa Patel, Shailesh Kumar Agrawal, Aditya Channabasappa, Nikhil K. Niranjan, Ankush K. Chandra Das, Bhabesh Pandey, Megha K. Tiwari, Sita Prasad Gaihre, Milan Mpox vaccination in global perspective: priorities and challenges |
title | Mpox vaccination in global perspective: priorities and challenges |
title_full | Mpox vaccination in global perspective: priorities and challenges |
title_fullStr | Mpox vaccination in global perspective: priorities and challenges |
title_full_unstemmed | Mpox vaccination in global perspective: priorities and challenges |
title_short | Mpox vaccination in global perspective: priorities and challenges |
title_sort | mpox vaccination in global perspective: priorities and challenges |
topic | Correspondence, Commentaries, Perspectives |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10205209/ https://www.ncbi.nlm.nih.gov/pubmed/37228971 http://dx.doi.org/10.1097/MS9.0000000000000550 |
work_keys_str_mv | AT ranajigyasa mpoxvaccinationinglobalperspectiveprioritiesandchallenges AT patelshaileshkumar mpoxvaccinationinglobalperspectiveprioritiesandchallenges AT agrawaladitya mpoxvaccinationinglobalperspectiveprioritiesandchallenges AT channabasappanikhilk mpoxvaccinationinglobalperspectiveprioritiesandchallenges AT niranjanankushk mpoxvaccinationinglobalperspectiveprioritiesandchallenges AT chandradasbhabesh mpoxvaccinationinglobalperspectiveprioritiesandchallenges AT pandeymeghak mpoxvaccinationinglobalperspectiveprioritiesandchallenges AT tiwarisitaprasad mpoxvaccinationinglobalperspectiveprioritiesandchallenges AT gaihremilan mpoxvaccinationinglobalperspectiveprioritiesandchallenges |